InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+13.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Farkas Charles, Director. Insider active across 1 company, notably CONMED Corp. Aggregated, 11 reports have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €252k. History available since 1 June 2021. The latest transaction was disclosed on 2 June 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Farkas Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
668 shares0Common StockSEC:0000816956-26-000069:0
1,103 shares@ US$53.53515.0% of flowCommon StockSEC:0000816956-25-000042:0
479 shares0Common StockSEC:0001127602-25-016762:0
1,000 shares@ US$55.7017.1% of flowCommon StockSEC:0001127602-25-016068:0
4,000 shares@ US$56.94270.4% of flowCommon StockSEC:0001127602-25-013471:0
1,000 shares@ US$39.6412.5% of flowCommon StockSEC:0001127602-24-023639:0
302 shares0Common StockSEC:0001127602-24-017849:0
335 shares0Common StockSEC:0001127602-23-017622:0
812 shares0Common StockSEC:0001127602-22-016538:0
1,521 shares0Common StockSEC:0001127602-21-018898:0
332 sharesCommon StockSEC:0001127602-16-035487:0
Canonical exit: 3 Apr 2016 (T+90)
11 of 11 declarations
About Farkas Charles
Farkas Charles is Administrateur and Director at CONMED Corp. He has 11 filings, and across the sampled recent filings, the transactions run from 2016-01-04 to 2026-06-03, with EUR 0 in purchases and EUR 251646 in sales; the most common transaction nature is Levée d'options.
